The Biden administration has announced that it will target certain drugs
for price negotiations in an effort to lower Medicare costs. The
administration has identified 200 drugs that it believes are overpriced and
that could be subject to negotiations. The negotiations are expected to
begin in 2023.
for price negotiations in an effort to lower Medicare costs. The
administration has identified 200 drugs that it believes are overpriced and
that could be subject to negotiations. The negotiations are expected to
begin in 2023.
